Completed PHASE4 INTERVENTIONAL 2-arm NCT01339819

Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-1)

Sponsor: Deutsches Herzzentrum Muenchen

Updated 5 times since 2017 Last updated: Jul 1, 2013 Started: Apr 30, 2011 Primary completion: May 31, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Deutsches Herzzentrum Muenchen and has accumulated 5 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deutsches Herzzentrum Muenchen

Data source: Deutsches Herzzentrum Muenchen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany